Based on research at KU Leuven, Ghent University and VIB, Aphea.Bio is working on a product that can increase crop yield while protecting against fungal diseases.

Illumina Ventures has led a series A round for SerImmune, which will use the funding to enhance its immune system mapping platform.

Polytech Ecosystem Ventures-backed BlueFox has collected $7m in series A capital from investors including Panasonic.

Existing shareholders, including IP Group and Finance Wales, have supplied additional capital to Cardiff spinout Alesi Surgical.

Based on research conducted at University of Oxford and Netherlands Cancer Institute, Scenic Biotech has raised $7.3m to commercialise technology that tackles diseases on the genetic level.

Multi-asset class portfolio management platform Solovis has secured $8m from a consortium that included existing backer Northwestern University.

Osage University Partners has contributed to a second funding round for SiFive, which produces semiconductor technology developed by UC Berkeley researchers.

Allied Minds-backed satellite communication technology developer BridgeSat has closed a $6m series A round.

Cambridge Enterprise and Cambridge Innovation Capital both participated in the funding round, which is based on research at the Cambridge Institute for Medical Research.